180 related articles for article (PubMed ID: 10718334)
1. Selectivity of the diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2, 3-dihydro-2-thioxo-4(1H)quinazolinone (R59949) among diacylglycerol kinase subtypes.
Jiang Y; Sakane F; Kanoh H; Walsh JP
Biochem Pharmacol; 2000 Apr; 59(7):763-72. PubMed ID: 10718334
[TBL] [Abstract][Full Text] [Related]
2. Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells.
Du X; Jiang Y; Qian W; Lu X; Walsh JP
Biochem J; 2001 Jul; 357(Pt 1):275-82. PubMed ID: 11415460
[TBL] [Abstract][Full Text] [Related]
3. Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells.
Meinhardt G; Eppinger E; Schmidmaier R
Anticancer Drugs; 2002 Aug; 13(7):725-33. PubMed ID: 12187329
[TBL] [Abstract][Full Text] [Related]
4. Evaluations of the selectivities of the diacylglycerol kinase inhibitors R59022 and R59949 among diacylglycerol kinase isozymes using a new non-radioactive assay method.
Sato M; Liu K; Sasaki S; Kunii N; Sakai H; Mizuno H; Saga H; Sakane F
Pharmacology; 2013; 92(1-2):99-107. PubMed ID: 23949095
[TBL] [Abstract][Full Text] [Related]
5. R59949, a diacylglycerol kinase inhibitor, inhibits inducible nitric oxide production through decreasing transplasmalemmal L-arginine uptake in vascular smooth muscle cells.
Shimomura T; Nakano T; Goto K; Wakabayashi I
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):207-214. PubMed ID: 27909743
[TBL] [Abstract][Full Text] [Related]
6. Dual activities of ritanserin and R59022 as DGKα inhibitors and serotonin receptor antagonists.
Boroda S; Niccum M; Raje V; Purow BW; Harris TE
Biochem Pharmacol; 2017 Jan; 123():29-39. PubMed ID: 27974147
[TBL] [Abstract][Full Text] [Related]
7. Depression of type I diacylglycerol kinases in pancreatic β-cells from male mice results in impaired insulin secretion.
Kurohane Kaneko Y; Kobayashi Y; Motoki K; Nakata K; Miyagawa S; Yamamoto M; Hayashi D; Shirai Y; Sakane F; Ishikawa T
Endocrinology; 2013 Nov; 154(11):4089-98. PubMed ID: 24035999
[TBL] [Abstract][Full Text] [Related]
8. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.
Bursell SE; Takagi C; Clermont AC; Takagi H; Mori F; Ishii H; King GL
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2711-20. PubMed ID: 9418723
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thrombin-induced Ca²⁺ influx in platelets by R59949, an inhibitor of diacylglycerol kinase.
Marumo M; Nakano T; Takeda Y; Goto K; Wakabayashi I
J Pharm Pharmacol; 2012 Jun; 64(6):855-61. PubMed ID: 22571264
[TBL] [Abstract][Full Text] [Related]
10. The role of endogenously formed diacylglycerol in the propagation and termination of platelet activation. A biochemical and functional analysis using the novel diacylglycerol kinase inhibitor, R 59 949.
de Chaffoy de Courcelles D; Roevens P; Van Belle H; Kennis L; Somers Y; De Clerck F
J Biol Chem; 1989 Feb; 264(6):3274-85. PubMed ID: 2536741
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of diacylglycerol kinase theta mediates adenosine-dependent hepatocyte preconditioning.
Baldanzi G; Alchera E; Imarisio C; Gaggianesi M; Dal Ponte C; Nitti M; Domenicotti C; van Blitterswijk WJ; Albano E; Graziani A; Carini R
Cell Death Differ; 2010 Jun; 17(6):1059-68. PubMed ID: 20057501
[TBL] [Abstract][Full Text] [Related]
12. Dual effect of reduced type I diacylglycerol kinase activity on insulin secretion from MIN6 β-cells.
Sawatani T; Kaneko YK; Ishikawa T
J Pharmacol Sci; 2019 Jun; 140(2):178-186. PubMed ID: 31279581
[TBL] [Abstract][Full Text] [Related]
13. Activation of HIF-prolyl hydroxylases by R59949, an inhibitor of the diacylglycerol kinase.
Temes E; Martín-Puig S; Acosta-Iborra B; Castellanos MC; Feijoo-Cuaresma M; Olmos G; Aragonés J; Landazuri MO
J Biol Chem; 2005 Jun; 280(25):24238-44. PubMed ID: 15849364
[TBL] [Abstract][Full Text] [Related]
14. Diacylglycerol kinase alpha activity promotes survival of CD4+ 8+ double positive cells during thymocyte development.
Outram SV; Crompton T; Merida I; Varas A; Martinez-A C
Immunology; 2002 Apr; 105(4):391-8. PubMed ID: 11985659
[TBL] [Abstract][Full Text] [Related]
15. Streptococcus mutans diacylglycerol kinase homologue: a potential target for anti-caries chemotherapy.
Shibata Y; Kawada-Matsuo M; Shirai Y; Saito N; Li D; Yamashita Y
J Med Microbiol; 2011 May; 60(Pt 5):625-630. PubMed ID: 21317193
[TBL] [Abstract][Full Text] [Related]
16. Diacylglycerol kinase gamma serves as an upstream suppressor of Rac1 and lamellipodium formation.
Tsushima S; Kai M; Yamada K; Imai S; Houkin K; Kanoh H; Sakane F
J Biol Chem; 2004 Jul; 279(27):28603-13. PubMed ID: 15102830
[TBL] [Abstract][Full Text] [Related]
17. Identification of ritanserin analogs that display DGK isoform specificity.
Granade ME; Manigat LC; Lemke MC; Purow BW; Harris TE
Biochem Pharmacol; 2022 Mar; 197():114908. PubMed ID: 34999054
[TBL] [Abstract][Full Text] [Related]
18. The diacylglycerol kinase inhibitor, R59949, potentiates secretion but not increased phosphorylation of a 47 kDalton protein in human platelets.
Rodríguez-Liñares B; Walker T; Watson S
Biochem Pharmacol; 1991 Mar; 41(5):835-8. PubMed ID: 1847818
[TBL] [Abstract][Full Text] [Related]
19. A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune response.
Liu K; Kunii N; Sakuma M; Yamaki A; Mizuno S; Sato M; Sakai H; Kado S; Kumagai K; Kojima H; Okabe T; Nagano T; Shirai Y; Sakane F
J Lipid Res; 2016 Mar; 57(3):368-79. PubMed ID: 26768655
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of HL-60 cells to granulocytes involves regulation of select diacylglycerol kinases (DGKs).
Batista EL; Warbington M; Badwey JA; Van Dyke TE
J Cell Biochem; 2005 Mar; 94(4):774-93. PubMed ID: 15578578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
